Patient Basic Information Patient: Mr. Timothy (Timothy King) Nationality: Chile Diagnosis: Facial Myeloma Clinical Hospital: University of Ningbo Affiliated First Hospital Treatment Program: Stem Cell Transplantation+ Supporting Treatment Accommodation Days: 95 days Treatment Cost: About 339744 yuan Treatment Effect: Functional Recovery The patient is from Chile and was diagnosed with facial myeloma locally. Upon arrival at the First Affiliate Hospital of the University of Ningbo, the International Medical Services team arranged for the first time multidisciplinary MDT sessions for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and placement services throughout the treatment process.
After 95 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, the test indicators returned to normal areas and successfully reached the hospital standard. Treatment results: Patient's final functional recovery. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to monitor the recovery through a remote follow-up system.
'Mr. Timothy has criticized the case as a typical case of cross-border suspected seriousness clinical cases. The University of Ningbo affiliated First Hospital relies on a multidisciplinary collaborative mechanism to develop a stem cell transplant + support treatment program for facial myeloma, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a shorthand for the regulation of international visitor medical services processes.
(Figure is taken from the official news report of the University of Ningbo affiliated First Hospital and medical scene information)